Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen-derived toxins are a broad class of virulence factors produced by microorganisms, including bacteria, fungi, and viruses, that cause damage to host tissues or interfere with normal biological processes (Popoff, 2014). These toxins are generally categorized into exotoxins, which are proteins secreted by living pathogens, and endotoxins, such as lipopolysaccharides, which are released upon the death and lysis of Gram-negative bacteria (StatPearls, 2023). Their mechanisms of action are diverse, involving the disruption of host cell membranes, inhibition of protein synthesis, or the subversion of intracellular signaling pathways to facilitate infection (NIH MeSH). In clinical medicine, these toxins are critical therapeutic targets, particularly in diseases where the toxin is the primary cause of pathology, such as Clostridioides difficile infection, anthrax, and botulism (FDA, 2016). Therapeutic strategies include the use of monoclonal antibodies and antitoxins that neutralize the toxins by blocking their binding to host receptors or preventing their entry into cells (FDA, 2016). While highly effective, the use of these agents can be limited by the timing of administration and potential immunogenic reactions in the patient (StatPearls, 2023).
Neutralization of toxin activity by preventing binding to host cell receptors or inhibiting translocation into the cytosol.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen-derived toxins.